-The Hindu "Collusion with Ajit Pawar to get Vidarbha land for his NGO" Training its guns on the Bharatiya Janata Party, India Against Corruption (IAC) on Wednesday alleged that the party president Nitin Gadkari took undue favours from the Maharashtra government in allotment of land acquired from Vidarbha farmers for a “public purpose.” For their generations-old land the farmers were compensated with a paltry sum of Rs. 5,000 per acre in 1981-82. Addressing...

-The Economic Times MUMBAI: The Reserve Bank of India has revised the definition of priority sector to include corporates engaged in agriculture and allied activities, and amended the limits for certain categories. In a circular issued to commercial banks on Wednesday, the RBI has clarified that loans to corporates, including companies formed by individual farmers, partnership firms and co-operatives of farmers directly engaged in agriculture and allied activities, will now be considered...

-Outlook The Election Commission has come across instances of suspected violations of the Foreign Contribution Regulation Act by Congress and the BJP in their acceptance of donations from subsidiaries of multi-national firm Vedanta group. An investigation by the EC, carried out with the help of the I-T department, has found that both the parties had received about Rs 5 crore each from two subsidiaries of the Vedanta group -- Sterlite Industries and...

-Live Mint Bill will be put before cabinet in next few weeks; legislation is expected to address rehabilitation, resettlement  New Delhi: The government moved a step closer to put in place a new land acquisition policy, after a ministerial panel overcame differences and struck a compromise. The Bill will now be put before the Union cabinet for its approval in the next few weeks. If indeed the government sticks to the proposed...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...